BC3195
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BC3195, covering 2024-08-12 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]